Miller, Jessica M.
Meki, Moustafa H.
Elnakib, Ahmed
Ou, Qinghui
Abouleisa, Riham R. E.
Tang, Xian-Liang
Salama, Abou Bakr M.
Gebreil, Ahmad
Lin, Cindy
Abdeltawab, Hisham
Khalifa, Fahmi
Hill, Bradford G.
Abi-Gerges, Najah
Bolli, Roberto
El-Baz, Ayman S.
Giridharan, Guruprasad A.
Mohamed, Tamer M. A. http://orcid.org/0000-0002-8435-808X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL147921, F32HL149140)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (P30GM127607)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Defense (W81XWH-20-1-0419)
Article History
Received: 7 February 2022
Accepted: 30 August 2022
First Online: 9 September 2022
Competing interests
: T.M.A.M. holds equities at Tenaya Therapeutics. G.G. consults for NuPulseCV. N.A. is the chief scientific officer and holds equities at Anabios. All other authors declare no competing interest.